1-19 of 19
bcl2 gene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Clinical Trials & Observations
Luciano J. Costa, Faith E. Davies, Gregory P. Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L. Kaufman, Wan-Jen Hong, Monique Dail, Ahmed Hamed Salem, Xiaoqing Yang, Abdullah A. Masud, Wijith Munasinghe, Jeremy A. Ross, Orlando F. Bueno, Shaji K. Kumar, Edward A. Stadtmauer
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3748–3759.
https://doi.org/10.1182/bloodadvances.2020004146
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Clinical Trials & Observations
Alison R. Walker, Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt, Krzysztof Mrózek, Andrew J. Carroll, Ann-Kathrin Eisfeld, Eunice S. Wang, Sawyer Jacobson, Jonathan E. Kolitz, Mohan Thakuri, Grerk Sutamtewagul, Ravi Vij, Robert K. Stuart, John C. Byrd, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2775–2787.
https://doi.org/10.1182/bloodadvances.2021004233
Published: 2021
Includes: Supplemental data
Journal Articles

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Clinical Trials & Observations
Alessandra Di Grande, Sofie Peirs, Paul D. Donovan, Maaike Van Trimpont, Julie Morscio, Beatrice Lintermans, Lindy Reunes, Niels Vandamme, Steven Goossens, Hien Anh Nguyen, Arnon Lavie, Richard B. Lock, Jochen H. M. Prehn, Pieter Van Vlierberghe, Triona Ní Chonghaile
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1963–1976.
https://doi.org/10.1182/bloodadvances.2021004177
Published: 2021
Includes: Supplemental data
Journal Articles

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Blake S. Moses, Samantha McCullough, Jennifer M. Fox, Bryan T. Mott, Søren M. Bentzen, MinJung Kim, Jeffrey W. Tyner, Rena G. Lapidus, Ashkan Emadi, Michelle A. Rudek, Tami J. Kingsbury, Curt I. Civin
Journal: Blood Advances
Blood Adv (2021) 5 (3): 711–724.
https://doi.org/10.1182/bloodadvances.2020003429
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features

Clinical Trials & Observations
Xiaolong Alan Zhou, Jingyi Yang, Kimberly G. Ringbloom, Maria Estela Martinez-Escala, Kristen E. Stevenson, Alexander T. Wenzel, Damiano Fantini, Haley K. Martin, Andrea P. Moy, Elizabeth A. Morgan, Shannon Harkins, Christian N. Paxton, Bo Hong, Erica F. Andersen, Joan Guitart, David M. Weinstock, Lorenzo Cerroni, Jaehyuk Choi, Abner Louissaint, Jr
Journal: Blood Advances
Blood Adv (2021) 5 (3): 649–661.
https://doi.org/10.1182/bloodadvances.2020002469
Published: 2021
Includes: Supplemental data
Journal Articles

PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax

Neus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, Anella Yahiaoui, Juan G. Valero, Ferran Nadeu, Guillem Clot, Miriam Di Re, Marc Corbera-Bellalta, Laura Magnano, Alfredo Rivas-Delgado, Anna Enjuanes, Silvia Beà, Maria C. Cid, Elías Campo, Joan Montero, Daniel J. Hodson, Armando López-Guillermo, Dolors Colomer, Stacey Tannheimer, Patricia Pérez-Galán
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4217–4231.
https://doi.org/10.1182/bloodadvances.2020001584
Published: 2020
Includes: Supplemental data
Journal Articles

Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma

Clinical Trials & Observations
Leo Meriranta, Annika Pasanen, Amjad Alkodsi, Jari Haukka, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3742–3753.
https://doi.org/10.1182/bloodadvances.2020001727
Published: 2020
Includes: Supplemental data
Journal Articles

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman Seshan, Jessica A. Lavery, Connie Batlevi, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, M. Lia Palomba, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3382–3390.
https://doi.org/10.1182/bloodadvances.2020001551
Published: 2020
Includes: Supplemental data
Journal Articles

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

Thomas E. C. Cummin, Kerry L. Cox, Tom D. Murray, Anna H. Turaj, Lisa Dunning, Vikki L. English, Rachel Fell, Graham Packham, Yan Ma, Ben Powell, Peter W. M. Johnson, Mark S. Cragg, Matthew J. Carter
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3316–3328.
https://doi.org/10.1182/bloodadvances.2020002231
Published: 2020
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data
Journal Articles

JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL

Sara Yumeen, Fatima N. Mirza, Julia M. Lewis, Amber Loren O. King, Sa Rang Kim, Kacie R. Carlson, Sheila R. Umlauf, Yulia V. Surovtseva, Francine M. Foss, Michael Girardi
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2213–2226.
https://doi.org/10.1182/bloodadvances.2020001756
Published: 2020
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data
Journal Articles

Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia

Victoria M. Smith, Oliver Lomas, Donna Constantine, Lianne Palmer, Anna H. Schuh, David Bruce, Oksana Gonchar, Salvador Macip, Sandrine Jayne, Martin J. S. Dyer, Toby A. Eyre
Journal: Blood Advances
Blood Adv (2020) 4 (3): 525–529.
https://doi.org/10.1182/bloodadvances.2019000917
Published: 2020
Includes: Supplemental data
Journal Articles

BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines

Sarah T. Diepstraten, Catherine Chang, Lin Tai, Jia-nan Gong, Ping Lan, Alexander C. Dowell, Graham S. Taylor, Andreas Strasser, Gemma L. Kelly
Journal: Blood Advances
Blood Adv (2020) 4 (2): 356–366.
https://doi.org/10.1182/bloodadvances.2019000541
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Clinical Trials & Observations
Pallawi Torka, Shalin K. Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros, Emily C. Ayers, Daniel J. Landsburg, David A. Bond, Kami J. Maddocks, Anshu Giri, Brian Hess, Luu Q. Pham, Ranjana Advani, Yang Liu, Stefan Klaus Barta, Julie M. Vose, Michael C. Churnetski, Jonathon B. Cohen, Madelyn Burkart, Reem Karmali, Joanna Zurko, Amitkumar Mehta, Adam J. Olszewski, Sarah Lee, Brian T. Hill, Timothy F. Burns, Frederick Lansigan, Emma Rabinovich, David Peace, Adrienne Groman, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2020) 4 (2): 253–262.
https://doi.org/10.1182/bloodadvances.2019000875
Published: 2020
Journal Articles

Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting

Anne Slomp, Laura M. Moesbergen, Jia-nan Gong, Marta Cuenca, Peter A. von dem Borne, Pieter Sonneveld, David C. S. Huang, Monique C. Minnema, Victor Peperzak
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4202–4214.
https://doi.org/10.1182/bloodadvances.2019000702
Published: 2019
Includes: Supplemental data
Journal Articles

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Clinical Trials & Observations
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2013–2021.
https://doi.org/10.1182/bloodadvances.2019000251
Published: 2019
Journal Articles

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy

Clinical Trials & Observations
Daniel J. Landsburg, Mitchell E. Hughes, Alexa Koike, David Bond, Kami J. Maddocks, Ling Guo, Allison M. Winter, Brian T. Hill, Sarah L. Ondrejka, Eric D. Hsi, Sunita D. Nasta, Jakub Svoboda, Stephen J. Schuster, Agata M. Bogusz
Journal: Blood Advances
Blood Adv (2019) 3 (2): 132–135.
https://doi.org/10.1182/bloodadvances.2018026401
Published: 2019
Journal Articles

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology

Lauren C. Chong, Susana Ben-Neriah, Graham W. Slack, Ciara Freeman, Daisuke Ennishi, Anja Mottok, Brett Collinge, Pau Abrisqueta, Pedro Farinha, Merrill Boyle, Barbara Meissner, Robert Kridel, Alina S. Gerrie, Diego Villa, Kerry J. Savage, Laurie H. Sehn, Reiner Siebert, Ryan D. Morin, Randy D. Gascoyne, Marco A. Marra, Joseph M. Connors, Andrew J. Mungall, Christian Steidl, David W. Scott
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2755–2765.
https://doi.org/10.1182/bloodadvances.2018023572
Published: 2018
Includes: Supplemental data